The increasing incidence of sexually transmitted infections (STIs) around the globe highlights the urgent need to address this important public health concern. Early identification of these infections is crucial because it enables patients to receive treatment rapidly, which lowers their risk of experiencing life-threatening complications and minimizes the potential for transmission within the community. To test for STIs, scientists currently employ several methods.
Cell & Molecular Biology
Reproductive healthcare transformed by genetic screening
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
